Secreted virulence factors and immune evasion in visceral leishmaniasis

Journal of Leukocyte Biology

Volumn 91, Issue 6, 2012, Pages 887-899

  Lambertz, Ulrike ^a   Silverman, Judith Maxwell ^a   Nandan, Devki ^a   Robert McMaster, W ^a   Clos, Joachim ^a   Foster, Leonard J ^b   Reiner, Neil E ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Exosomes; Kinase; Macrophage; Phosphatase; Protein secretion; Vaccine

Indexed keywords

FRUCTOSE BISPHOSPHATE ALDOLASE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; JANUS KINASE 2; LEISHMANOLYSIN; MAMMALIAN TARGET OF RAPAMYCIN; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN EF 1ALPHA; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE SHP 1; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

BIOGENESIS; CHROMATOGRAPHY; CLINICAL TRIAL (TOPIC); CYTOSOL; EFFECTOR CELL; ENZYME ACTIVITY; EXOSOME; HOST CELL; HUMAN; IMMUNE EVASION; IMMUNOPROPHYLAXIS; LEISHMANIA DONOVANI; LEISHMANIA MEXICANA; LYSOSOME MEMBRANE; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PHAGOLYSOSOME; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VISCERAL LEISHMANIASIS;

ANIMALS; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN TRANSPORT; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; PROTO-ONCOGENE PROTEINS C-AKT; PROTOZOAN PROTEINS; SIGNAL TRANSDUCTION; VIRULENCE FACTORS;

EID: 84861921052     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0611326     Document Type: Review

References (122)

1. Neave, S. (1904) "Leishmania Donovani" in the Soudan. Br. Med. J. 1, 1252.
2. Medzhitov, R. (2007) Recognition of microorganisms and activation of the immune response. Nature 449, 819-826.
3. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jornvall, H., Wigzell, H., Gudmundsson, G. H. (2000) The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-3093.
4. Duits, L. A., Ravensbergen, B., Rademaker, M., Hiemstra, P. S., Nibbering, P. H. (2002) Expression of β-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 106, 517-525.
5. Olivier, M., Brownsey, R. W., Reiner, N. E. (1992) Defective stimulusresponse coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C. Proc. Natl. Acad. Sci. USA 89, 7481-7485.
6. Descoteaux, A., Matlashewski, G., Turco, S. J. (1992) Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J. Immunol. 149, 3008-3015.
7. Balaraman, S., Singh, V. K., Tewary, P., Madhubala, R. (2005) Leishmania lipophosphoglycan activates the transcription factor activating protein 1 in J774A. 1 macrophages through the extracellular signal-related kinase (ERK) and p38 mitogen-activated protein kinase. Mol. Biochem. Parasitol. 139, 117-127.
8. Proudfoot, L., Nikolaev, A. V., Feng, G. J., Wei, W. Q., Ferguson, M. A., Brimacombe, J. S., Liew, F. Y. (1996) Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc. Natl. Acad. Sci. USA 93, 10984-10989.
9. Kavoosi, G., Ardestani, S. K., Kariminia, A., Abolhassani, M., Turco, S. J. (2006) Leishmania major: reactive oxygen species and interferon γ induction by soluble lipophosphoglycan of stationary phase promastigotes. Exp. Parasitol. 114, 323-328.
10. Nandan, D., Yi, T., Lopez, M., Lai, C., Reiner, N. E. (2002) Leishmania EF-1α activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J. Biol. Chem. 277, 50190-50197.
11. Silverman, J. M., Chan, S. K., Robinson, D. P., Dwyer, D. M., Nandan, D., Foster, L. J., Reiner, N. E. (2008) Proteomic analysis of the secretome of Leishmania donovani. Genome Biol. 9, R35.
12. McNeely, T. B., Turco, S. J. (1987) Inhibition of protein kinase C activity by the Leishmania donovani lipophosphoglycan. Biochem. Biophys. Res. Commun. 148, 653-657.
13. Bhattacharyya, S., Ghosh, S., Sen, P., Roy, S., Majumdar, S. (2001) Selective impairment of protein kinase C isotypes in murine macrophage by Leishmania donovani. Mol. Cell. Biochem. 216, 47-57.
14. Holm, A., Tejle, K., Magnusson, K. E., Descoteaux, A., Rasmusson, B. (2001) Leishmania donovani lipophosphoglycan causes periphagosomal actin accumulation: correlation with impaired translocation of PKCα and defective phagosome maturation. Cell. Microbiol. 3, 439-447.
15. Holm, A., Tejle, K., Gunnarsson, T., Magnusson, K. E., Descoteaux, A., Rasmusson, B. (2003) Role of protein kinase C α for uptake of unopsonized prey and phagosomal maturation in macrophages. Biochem. Biophys. Res. Commun. 302, 653-658.
16. Pingel, S., Wang, Z. E., Locksley, R. M. (1998) Distribution of protein kinase C isoforms after infection of macrophages with Leishmania major. Infect. Immun. 66, 1795-1799.
17. Pereira, R. M., Teixeira, K. L., Barreto-de-Souza, V., Calegari-Silva, T. C., De-Melo, L. D., Soares, D. C., Bou-Habib, D. C., Silva, A. M., Saraiva, E. M., Lopes, U. G. (2010) Novel role for the double-stranded RNA-activated protein kinase PKR: modulation of macrophage infection by the protozoan parasite Leishmania. FASEB J. 24, 617-626.
18. Vivarini, A. C., Pereira, R. M., Teixeira, K. L., Calegari-Silva, T. C., Bellio, M., Laurenti, M. D., Corbett, C. E., Gomes, C. M., Soares, R. P., Silva, A. M. Silveira, F. T., Lopes, U. G. (2011) Human cutaneous leishmaniasis: interferon-dependent expression of double-stranded RNAdependent protein kinase (PKR) via TLR2. FASEB J. 25, 4162-4173.
19. Blanchette, J., Racette, N., Faure, R., Siminovitch, K. A., Olivier, M. (1999) Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-γ-triggered JAK2 activation. Eur. J. Immunol. 29, 3737-3744.
20. Nandan, D., Reiner, N. E. (1995) Attenuation of γ interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1. Infect. Immun. 63, 4495-4500.
21. Matte, C., Descoteaux, A. (2010) Leishmania donovani amastigotes impair γ interferon-induced STAT1α nuclear translocation by blocking the interaction between STAT1α and importin-α5. Infect. Immun. 78, 3736-3743.
22. Forget, G., Gregory, D. J., Whitcombe, L. A., Olivier, M. (2006) Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production. Infect. Immun. 74, 6272-6279.
23. Ruhland, A., Leal, N., Kima, P. E. (2007) Leishmania promastigotes activate PI3K/Akt signalling to confer host cell resistance to apoptosis. Cell. Microbiol. 9, 84-96.
24. Ruhland, A., Kima, P. E. (2009) Activation of PI3K/Akt signaling has a dominant negative effect on IL-12 production by macrophages infected with Leishmania amazonensis promastigotes. Exp. Parasitol. 122, 28-36.
25. Fukao, T., Tanabe, M., Terauchi, Y., Ota, T., Matsuda, S., Asano, T., Kadowaki, T., Takeuchi, T., Koyasu, S. (2002) PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3, 875-881.
26. Martin, M., Schifferle, R. E., Cuesta, N., Vogel, S. N., Katz, J., Michalek, S. M. (2003) Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J. Immunol. 171, 717-725.
27. Waggoner, S. N., Cruise, M. W., Kassel, R., Hahn, Y. S. (2005) gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J. Immunol. 175, 4706-4714.
28. Moser, C., Hougen, H. P., Song, Z., Rygaard, J., Kharazmi, A., Hoiby, N. (1999) Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response. APMIS 107, 1093-1100.
29. Trinchieri, G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigenspecific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
30. Reiner, N. E. (1994) Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol. Today 15, 374-381.
31. Carrera, L., Gazzinelli, R. T., Badolato, R., Hieny, S., Muller, W., Kuhn, R., Sacks, D. L. (1996) Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183, 515-526.
32. Bennett, C. L., Misslitz, A., Colledge, L., Aebischer, T., Blackburn, C. C. (2001) Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. Eur. J. Immunol. 31, 876-883.
33. Kuroda, S., Nishio, M., Sasaki, T., Horie, Y., Kawahara, K., Sasaki, M., Natsui, M., Matozaki, T., Tezuka, H., Ohteki, T. Förster, I., Mak, T. W., Nakano, T., Suzuki, A. (2008) Effective clearance of intracellular Leishmania major in vivo requires Pten in macrophages. Eur. J. Immunol. 38, 1331-1340.
34. Ohtani, M., Nagai, S., Kondo, S., Mizuno, S., Nakamura, K., Tanabe, M., Takeuchi, T., Matsuda, S., Koyasu, S. (2008) Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 112, 635-643.
35. Cheekatla, S. S., Aggarwal, A., Naik, S. (2012) mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection. Med. Microbiol. Immunol. 201, 37-46.
36. Liu, D., Uzonna, J. E. (2010) The p110 δ isoform of phosphatidylinositol 3-kinase controls the quality of secondary anti-Leishmania immunity by regulating expansion and effector function of memory T cell subsets. J. Immunol. 184, 3098-3105.
37. Liu, D., Zhang, T., Marshall, A. J., Okkenhaug, K., Vanhaesebroeck, B., Uzonna, J. E. (2009) The p110δ isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J. Immunol. 183, 1921-1933.
38. Nandan, D., Camargo de, O. C., Moeenrezakhanlou, A., Lopez, M., Silverman, J. M., Subek, J., Reiner, N. E. (2012) Myeloid cell IL-10 production in response to leishmania involves inactivation of glycogen synthase kinase-3β downstream of phosphatidylinositol-3 kinase. J. Immunol. 188, 367-378.
39. Prive, C., Descoteaux, A. (2000) Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. Eur. J. Immunol. 30, 2235-2244.
40. Junghae, M., Raynes, J. G. (2002) Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages. Infect. Immun. 70, 5026-5035.
41. Nandan, D., Lo, R., Reiner, N. E. (1999) Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect. Immun. 67, 4055-4063.
42. Olivier, M., Romero-Gallo, B. J., Matte, C., Blanchette, J., Posner, B. I., Tremblay, M. J., Faure, R. (1998) Modulation of interferon-γ-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine Leishmaniasis progression. J. Biol. Chem. 273, 13944-13949.
43. Forget, G., Siminovitch, K. A., Brochu, S., Rivest, S., Radzioch, D., Olivier, M. (2001) Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur. J. Immunol. 31, 3185-3196.
44. Forget, G., Matte, C., Siminovitch, K. A., Rivest, S., Pouliot, P., Olivier, M. (2005) Regulation of the Leishmania-induced innate inflammatory response by the protein tyrosine phosphatase SHP-1. Eur. J. Immunol. 35, 1906-1917.
45. Spath, G. F., McDowell, M. A., Beverley, S. M. (2008) Leishmania major intracellular survival is not altered in SHP-1 deficient mev or CD45-/-mice. Exp. Parasitol. 120, 275-279.
46. Blanchette, J., bu-Dayyeh, I., Hassani, K., Whitcombe, L., Olivier, M. (2009) Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1). Immunology 127, 123-133.
47. Gomez, M. A., Contreras, I., Halle, M., Tremblay, M. L., McMaster, R. W., Olivier, M. (2009) Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases. Sci. Signal 2, ra58.
48. Kar, S., Ukil, A., Sharma, G., Das, P. K. (2010) MAPK-directed phosphatases preferentially regulate pro-and anti-inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms. J. Leukoc. Biol. 88, 9-20.
49. Marti, M., Good, R. T., Rug, M., Knuepfer, E., Cowman, A. F. (2004) Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science 306, 1930-1933.
50. Nandan, D., Tran, T., Trinh, E., Silverman, J. M., Lopez, M. (2007) Identification of leishmania fructose-1,6-bisphosphate aldolase as a novel activator of host macrophage Src homology 2 domain containing protein tyrosine phosphatase SHP-1. Biochem. Biophys. Res. Commun. 364, 601-607.
51. Magalhaes, K. G., Almeida, P. E., Atella, G. C., Maya-Monteiro, C. M., Castro-Faria-Neto, H. C., Pelajo-Machado, M., Lenzi, H. L., Bozza, M. T., Bozza, P. T. (2010) Schistosomal-derived lysophosphatidylcholine are involved in eosinophil activation and recruitment through Toll-like receptor-2-dependent mechanisms. J. Infect. Dis. 202, 1369-1379.
52. Hathout, Y. (2007) Approaches to the study of the cell secretome. Expert Rev. Proteomics 4, 239-248.
53. McConville, M. J., Mullin, K. A., Ilgoutz, S. C., Teasdale, R.D. (2002) Secretory pathway of trypanosomatid parasites. Microbiol. Mol. Biol. Rev. 66, 122-154.
54. Field, M. C., Natesan, S. K., Gabernet-Castello, C., Koumandou, V. L. (2007) Intracellular trafficking in the trypanosomatids. Traffic 8, 629-639.
55. Chenik, M., Lakhal, S., Ben Khalef, N., Zribi, L., Louzir, H., Dellagi, K. (2006) Approaches for the identification of potential excreted/secreted proteins of Leishmania major parasites. Parasitology 132, 493-509.
56. Kulkarni, M. M., McMaster, W. R., Kamysz, E., Kamysz, W., Engman, D. M., McGwire, B. S. (2006) The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptideinduced apoptotic killing. Mol. Microbiol. 62, 1484-1497.
57. Foth, B., Piani, A., Curtis, J. M., Ilg, T., McConville, M., Handman, E. (2002) Leishmania major proteophosphoglycans exist as membranebound and soluble forms and localize to the cell membrane, the flagellar pocket and the lysosome. Int. J. Parasitol. 32, 1701-1708.
58. Nickel, W., Seedorf, M. (2008) Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. Annu. Rev. Cell Dev. Biol. 24, 287-308.
59. Denny, P. W., Gokool, S., Russell, D. G., Field, M. C., Smith, D. F. (2000) Acylation-dependent protein export in Leishmania. J. Biol. Chem. 275, 11017-11025.
60. Silverman, J. M., Clos, J., Horakova, E., Wang, A. Y., Wiesgigl, M., Kelly, I., Lynn, M. A., McMaster, W. R., Foster, L. J., Levings, M. K., Reiner, N. E. (2010) Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. J. Immunol. 185, 5011-5022.
61. Silverman, J. M., Clos, J., de'Oliveira, C. C., Shirvani, O., Fang, Y., Wang, C., Foster, L. J., Reiner, N. E. (2010) An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J. Cell Sci. 123, 842-852.
62. Ranganathan, S., Garg, G. (2009) Secretome: clues into pathogen infection and clinical applications. Genome Med. 1, 113.
63. Shakarian, A. M., Dwyer, D. M. (1998) The Ld Cht1 gene encodes the secretory chitinase of the human pathogen Leishmania donovani. Gene 208, 315-322.
64. Bates, P. A., Dwyer, D. M. (1987) Biosynthesis and secretion of acid phosphatase by Leishmania donovani promastigotes. Mol. Biochem. Parasitol. 26, 289-296.
65. Vergnes, B., Sereno, D., Madjidian-Sereno, N., Lemesre, J. L., Ouaissi, A. (2002) Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death. Gene 296, 139-150.
66. Cuervo, P., De Jesus, J. B., Saboia-Vahia, L., Mendonca-Lima, L., Domont, G. B., Cupolillo, E. (2009) Proteomic characterization of the released/secreted proteins of Leishmania (Viannia) braziliensis promastigotes. J. Proteomics 73, 79-92.
67. DebRoy, S., Keenan, A. B., Ueno, N., Jeronimo, S. M., Donelson, J. E., Wilson, M. E. (2010) Leishmania infantum chagasi: a genome-based approach to identification of excreted/secreted proteins. Exp. Parasitol. 126, 582-591.
68. Corrales, R. M., Mathieu-Daudé, F., Garcia, D., Breniere, S. F., Sereno, D. (2010) An experimental approach for the identification of conserved secreted proteins in trypanosomatids. J. Biomed. Biotechnol. 2010, 752, 698.
69. McCall, L. I., Matlashewski, G. (2010) Localization and induction of the A2 virulence factor in Leishmania: evidence that A2 is a stress response protein. Mol. Microbiol. 77, 518-530.
70. Nandan, D., Reiner, N. E. (2005) Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1. Clin. Immunol. 114, 266-277.
71. Yao, C. (2010) Major surface protease of trypanosomatids: one size fits all? Infect. Immun. 78, 22-31.
72. Yao, C., Leidal, K. G., Brittingham, A., Tarr, D. E., Donelson, J. E., Wilson, M. E. (2002) Biosynthesis of the major surface protease GP63 of Leishmania chagasi. Mol. Biochem. Parasitol. 121, 119-128.
73. McGwire, B. S., O'Connell, W. A., Chang, K. P., Engman, D. M. (2002) Extracellular release of the glycosylphosphatidylinositol (GPI)-linked Leishmania surface metalloprotease, gp63, is independent of GPI phospholipolysis: implications for parasite virulence. J. Biol. Chem. 277, 8802-8809.
74. Ellis, M., Sharma, D. K., Hilley, J. D., Coombs, G. H., Mottram, J. C. (2002) Processing and trafficking of Leishmania mexicana GP63. Analysis using GP18 mutants deficient in glycosylphosphatidylinositol protein anchoring. J. Biol. Chem. 277, 27968-27974.
75. Weise, F., Stierhof, Y. D., Kuhn, C., Wiese, M., Overath, P. (2000) Distribution of GPI-anchored proteins in the protozoan parasite Leishmania, based on an improved ultrastructural description using high-pressure frozen cells. J. Cell Sci. 113, 4587-4603.
76. Denny, P. W., Field, M. C., Smith, D. F. (2001) GPI-anchored proteins and glycoconjugates segregate into lipid rafts in Kinetoplastida. FEBS Lett. 491, 148-153.
77. Bordier, C., Etges, R. J., Ward, J., Turner, M. J., Cardoso de Almeida, M. L. (1986) Leishmania and Trypanosoma surface glycoproteins have a common glycophospholipid membrane anchor. Proc. Natl. Acad. Sci. USA 83, 5988-5991.
78. Bouvier, J., Schneider, P., Etges, R., Bordier, C. (1990) Peptide substrate specificity of the membrane-bound metalloprotease of Leishmania. Biochemistry 29, 10113-10119.
79. Russell, D. G. (1987) The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes. Eur. J. Biochem. 164, 213-221.
80. McGwire, B. S., Chang, K. P., Engman, D. M. (2003) Migration through the extracellular matrix by the parasitic protozoan Leishmania is enhanced by surface metalloprotease gp63. Infect. Immun. 71, 1008-1010.
81. Yao, C., Donelson, J. E., Wilson, M. E. (2007) Internal and surface-localized major surface proteases of Leishmania spp. and their differential release from promastigotes. Eukaryot. Cell 6, 1905-1912.
82. Kulkarni, M. M., Jones, E. A., McMaster, W. R., McGwire, B. S. (2008) Fibronectin binding and proteolytic degradation by Leishmania and effects on macrophage activation. Infect. Immun. 76, 1738-1747.
83. Chaudhuri, G., Chaudhuri, M., Pan, A., Chang, K. P. (1989) Surface acid proteinase (gp63) of Leishmania mexicana. A metalloenzyme capa-ble of protecting liposome-encapsulated proteins from phagolysosomal degradation by macrophages. J. Biol. Chem. 264, 7483-7489.
84. McGwire, B., Chang, K. P. (1994) Genetic rescue of surface metalloproteinase (gp63)-deficiency in Leishmania amazonensis variants increases their infection of macrophages at the early phase. Mol. Biochem. Parasitol. 66, 345-347.
85. Chen, D. Q., Kolli, B. K., Yadava, N., Lu, H. G., Gilman-Sachs, A., Peterson, D. A., Chang, K. P. (2000) Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: modulation of gp63 level in promastigotes and their infection of macrophages in vitro. Infect. Immun. 68, 80-86.
86. Seay, M. B., Heard, P. L., Chaudhuri, G. (1996) Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes. Infect. Immun. 64, 5129-5137.
87. Lieke, T., Nylen, S., Eidsmo, L., McMaster, W. R., Mohammadi, A. M., Khamesipour, A., Berg, L., Akuffo, H. (2008) Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation. Clin. Exp. Immunol. 153, 221-230.
88. Garcia, M. R., Graham, S., Harris, R. A., Beverley, S. M., Kaye, P. M. (1997) Epitope cleavage by Leishmania endopeptidase(s) limits the efficiency of the exogenous pathway of major histocompatibility complex class I-associated antigen presentation. Eur. J. Immunol. 27, 1005-1013.
89. Corradin, S., Ransijn, A., Corradin, G., Roggero, M. A., Schmitz, A. A., Schneider, P., Mauel, J., Vergeres, G. (1999) MARCKS-related protein (MRP) is a substrate for the Leishmania major surface protease leishmanolysin (gp63). J. Biol. Chem. 274, 25411-25418.
90. Corradin, S., Mauel, J., Ransijn, A., Sturzinger, C., Vergeres, G. (1999) Down-regulation of MARCKS-related protein (MRP) in macrophages infected with Leishmania. J. Biol. Chem. 274, 16782-16787.
91. Contreras, I., Gomez, M. A., Nguyen, O., Shio, M. T., McMaster, R. W., Olivier, M. (2010) Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63. PLoS Pathog. 6, e1001148.
92. Gregory, D. J., Godbout, M., Contreras, I., Forget, G., Olivier, M. (2008) A novel form of NF-κB is induced by Leishmania infection: involvement in macrophage gene expression. Eur. J. Immunol. 38, 1071-1081.
93. Halle, M., Gomez, M. A., Stuible, M., Shimizu, H., McMaster, W. R., Olivier, M., Tremblay, M. L. (2009) The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation. J. Biol. Chem. 284, 6893-6908.
94. Bates, P. A., Hermes, I., Dwyer, D. M. (1989) Leishmania donovani: immunochemical localization and secretory mechanism of soluble acid phosphatase. Exp. Parasitol. 68, 335-346.
95. Shakarian, A. M., Joshi, M. B., Yamage, M., Ellis, S. L., Debrabant, A., Dwyer, D. M. (2003) Members of a unique histidine acid phosphatase family are conserved amongst a group of primitive eukaryotic human pathogens. Mol. Cell. Biochem. 245, 31-41.
96. Vannier-Santos, M. A., Martiny, A., Meyer-Fernandes, J. R., de Souza, W. (1995) Leishmanial protein kinase C modulates host cell infection via secreted acid phosphatase. Eur. J. Cell Biol. 67, 112-119.
97. Shakarian, A. M., Ellis, S. L., Mallinson, D. J., Olafson, R. W., Dwyer, D. M. (1997) Two tandemly arrayed genes encode the (histidine) secretory acid phosphatases of Leishmania donovani. Gene 196, 127-137.
98. Schaible, U. E., Schlesinger, P. H., Steinberg, T. H., Mangel, W. F., Kobayashi, T., Russell, D. G. (1999) Parasitophorous vacuoles of Leishmania mexicana acquire macromolecules from the host cell cytosol via two independent routes. J. Cell Sci. 112, 681-693.
99. Teitelbaum, R., Cammer, M., Maitland, M. L., Freitag, N. E., Condeelis, J., Bloom, B. R. (1999) Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc. Natl. Acad. Sci. USA 96, 15190-15195.
100. Mottram, J. C., Coombs, G. H., Alexander, J. (2004) Cysteine peptidases as virulence factors of Leishmania. Curr. Opin. Microbiol. 7, 375-381.
101. Keller, S., Sanderson, M. P., Stoeck, A., Altevogt, P. (2006) Exosomes: from biogenesis and secretion to biological function. Immunol. Lett. 107, 102-108.
102. Savina, A., Fader, C. M., Damiani, M. T., Colombo, M. I. (2005) Rab11 promotes docking and fusion of multivesicular bodies in a calciumdependent manner. Traffic 6, 131-143.
103. Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brugger, B., Simons, M. (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244-1247.
104. Mathivanan, S., Ji, H., Simpson, R. J. (2010) Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73, 1907-1920.
105. Thery, C., Ostrowski, M., Segura, E. (2009) Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593.
106. Ellis, T. N., Kuehn, M. J. (2010) Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol. Rev. 74, 81-94.
107. Silverman, J. M., Reiner, N. E. (2011) Exosomes and other microvesicles in infection biology: organelles with unanticipated phenotypes. Cell. Microbiol. 13, 1-9.
108. Hassani, K., Antoniak, E., Jardim, A., Olivier, M. (2011) Temperatureinduced protein secretion by Leishmania mexicana modulates macrophage signalling and function. PLoS One 6, e18724.
109. Krobitsch, S., Clos, J. (1999) A novel role for 100 kD heat shock proteins in the parasite Leishmania donovani. Cell Stress Chaperones 4, 191-198.
110. Hubel, A., Krobitsch, S., Horauf, A., Clos, J. (1997) Leishmania major Hsp100 is required chiefly in the mammalian stage of the parasite. Mol. Cell. Biol. 17, 5987-5995.
111. Peters, N. C., Kimblin, N., Secundino, N., Kamhawi, S., Lawyer, P., Sacks, D. L. (2009) Vector transmission of leishmania abrogates vaccine-induced protective immunity. PLoS Pathog. 5, e1000484.
112. Silvestre, R., Cordeiro-Da-Silva, A., Santarem, N., Vergnes, B., Sereno, D., Ouaissi, A. (2007) SIR2-deficient Leishmania infantum induces a defined IFN-γ/IL-10 pattern that correlates with protection. J. Immunol. 179, 3161-3170.
113. Coler, R. N., Reed, S. G. (2005) Second-generation vaccines against leishmaniasis. Trends Parasitol. 21, 244-249.
114. Bhowmick, S., Ravindran, R., Ali, N. (2007) Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response. Vaccine 25, 6544-6556.
115. Lindenstrom, T., Andersen, P., Agger, E. M. (2010) Determining adjuvant activity on T-cell function in vivo: Th cells. Methods Mol. Biol. 626, 213-229.
116. Yu, H., Jiang, X., Shen, C., Karunakaran, K. P., Jiang, J., Rosin, N. L., Brunham, R. C. (2010) Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of γ interferon (IFN-γ)/tumor necrosis factor α and IFN-γ/interleukin-17 double-positive CD4+ T cells. Infect. Immun. 78, 2272-2282.
117. Christensen, D., Korsholm, K. S., Rosenkrands, I., Lindenstrom, T., Andersen, P., Agger, E. M. (2007) Cationic liposomes as vaccine adjuvants. Expert Rev. Vaccines 6, 785-796.
118. Lindenstrom, T., Agger, E. M., Korsholm, K. S., Darrah, P. A., Aagaard, C., Seder, R. A., Rosenkrands, I., Andersen, P. (2009) Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J. Immunol. 182, 8047-8055.
119. Schnitzer, J. K., Berzel, S., Fajardo-Moser, M., Remer, K. A., Moll, H. (2010) Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major. Vaccine 28, 5785-5793.
120. Beauvillain, C., Juste, M. O., Dion, S., Pierre, J., Dimier-Poisson, I. (2009) Exosomes are an effective vaccine against congenital toxoplasmosis in mice. Vaccine 27, 1750-1757.
121. Aline, F., Bout, D., Amigorena, S., Roingeard, P., Dimier-Poisson, I. (2004) Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infect. Immun. 72, 4127-4137.
122. Zhang, H. G., Grizzle, W. E. (2011) Exosomes and cancer: a newly described pathway of immune suppression. Clin. Cancer Res. 17, 959-964.